3rd June 2020
Navenio, the healthcare scale-up whose location-based technology has been shown to double the throughput of hospital teams, has received c. £50k from the UK government and Innovate UK, the UK’s innovation agency, as part of a government boost for cutting-edge companies.
28th May 2020
Sarissa Biomedical , a Coventry-based biotech business has raised £1.2m for a new hand-held device that allows paramedics and emergency doctors to quickly diagnose patients who are having a stroke. Sarissa Biomedical has secured funds from a consortium of investors including the MEIF Proof of Concept & Early Stage Fund, which is managed by Mercia and part of the Midlands Engine Investment Fund, Mercia’s EIS funds, and private investors including Wren Capital and the Wood Family.
21st May 2020
The healthcare scale-up behind a location-based platform which has been shown to double team throughput, has announced £9m in series A funding led QBN Capital.
20th May 2020
MGB Biopharma, the Glasgow-based biopharmaceutical company developing a novel class of anti-infectives, has announced the successful conclusion of its Phase II clinical study into MGB-BP-3, for the treatment of Clostridium difficile Infection (CDI).
19th May 2020
Port Talbot-based Hybrisan has joined the fight against the Covid 19 pandemic having secured £500,000 equity investment from the Development Bank of Wales, private investors and a Smart Cymru grant from the Welsh Government. Hybrisan manufacture liquid sanitiser and use advanced nanotechnology to produce highly advanced material, impregnated with the liquid sanitiser for use in high quality personal protective equipment (PPE) for the NHS and other frontline workers. The liquid sanitiser developed by Hybrisan is 99.999% effective in killing coronavirus without alcohol, even on surfaces.
18th May 2020
A leading Welsh medtech company has received significant equity funding The Development Bank of Wales and Wealth Club to develop the digital element of a new rapid test to support authorities fighting the coronavirus pandemic.
Cardiff-based Bond Digital Health is part of an international consortium that is producing a diagnostic test for patients suspected of having Covid-19. The consortium was set up by Canadian company Sona Nanotech Inc. and includes GE Healthcare Life Sciences.
4th May 2020
QVentures is to lead the funding round in Glean.ly, a scalable repository for user experience research and insights.
Almost all companies rely on user experience and there is a growing need for companies to produce a unique user experience. Very few companies have the tools to allow employees to easily access and understand research previously carried out in their companies which often leads to duplicating work.
4th May 2020
Lifebit Biotech, a leading innovator in bioinformatics and cognitive software solutions, has closed its Series A funding round of US$7.5M (£6 million) led by Idinvest Partners, to fuel ongoing product innovations and global market expansion. Previous investors Pentech Ventures LLP, Beacon Capital, and Connect Ventures also participated in the round.
17th April 2020
Medopad has changed its name to Huma and has acquired two UK AI and wearable technology businesses, BioBeats and TLT. The rebrand and acquisitions support the company’s mission to use insights gathered by remote monitoring to help healthcare, life sciences and innovation partners understand, treat and prevent poor health. By collectively benefiting from the data people individually generate, Huma aims to give knowledge and power to individuals, while saving clinicians time, energy and valuable resources.
14th April 2020
Experts from the University of Birmingham’s Medical & Dental School, Health Technologies Institute, and the Royal Orthopaedic Hospital NHS Foundation Trust have designed a new piece of equipment to help prevent transmission of COVID-19 from patients to medical staff.
1st April 2020
Big Society Capital and Guy’s and St Thomas’s Charity have partnered to fund Good Food Fund, a new Accelerator and Venture Fund which will be backing food and drink challenger SME and start-up brands to help tackle childhood obesity. Business owners are invited to apply for a cut of the £1.8m Good Food Fund to come together in the fight against childhood obesity. The prototype fund will provide business support and allocate finances to brands committed to bringing healthier children’s brands to market. The Accelerator will be run by Mission Ventures and the Venture Capital Fund will be managed by Ascension Ventures.
1st April 2020
Gilde Healthcare has closed its $450 million venture and growth capital fund Gilde Healthcare V. The new fund, which was oversubscribed, targets growth opportunities in a broad range of healthcare sectors including digital health, medtech and therapeutics both in Europe and North America. The fund will have a special attention for private healthcare companies enabling improved care at affordable cost.